43.51 (-%)
As of Nov 21, 2024
Source:
Kymera Therapeutics, Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.
| Country | United States |
| Headquarters | watertown, massachusetts |
| Phone Number | 857-285-5314 |
| Industry | |
| CEO | Nello Mainolfi |
| Website | www.clinicaltrials.gov |